TCV Trust & Wealth Management 13F: New $245K Stake in CME

TCV Trust & Wealth Management opened a new position in CME Group Inc. (CME), adding 937 shares worth roughly $245,474 in a recent filing.

Reviewed by automated data checks against the source filing. How we make and check alerts

TCV Trust & Wealth Management opened a new position of 937 shares in CME Group Inc. ($CME), according to a 13F filing with the SEC dated October 16, 2026. It reported 937 shares worth $245,474 at the end of the quarter.

View the original 13F-HR filing on SEC EDGAR

CME CME Group Inc.
$293.87 +12.68% year to date
Daily close · Oct 16, 2026

Key Points

  • TCV Trust & Wealth Management opened a new stake in CME Group Inc. (CME), purchasing 937 shares valued at about $245,474.
  • CME trades recently around $290.33, sitting above both its 50-day and 200-day moving averages as it approaches its next earnings date.
  • Wall Street firms including UBS, TD Cowen, and Barclays recently updated their views on the stock ahead of upcoming reports.

Get $CME trade alerts by text

We text you when insiders, Congress or big funds trade $CME. Free.

Not investment advice. TradeTexts is not a registered investment adviser, and this automated CME Group Inc. alert may contain errors. Disclosures

TCV Trust & Wealth Management opened a new position in CME Group Inc. (CME), according to its latest Form 13F filing with the SEC on October 16, 2026. Because 13F filings look backward at holdings from the end of a prior quarter, this report reflects the fund's portfolio at that time and may not match its current holdings.

Inside TCV Trust & Wealth Management's CME Trade

The fund initiated a brand-new stake in the exchange operator, acquiring 937 shares. The reported value of the purchase was $245,474. Since this was a new buy, the position started from zero shares.

Other Institutional Activity in CME Group Inc.

Other large funds made adjustments to their CME holdings during the period. Blackrock Inc. reduced its holdings by 880,512 shares, ending with 30,566,342 shares worth about $8,982,530,774 after a 2.8% decrease. Vanguard Capital Management LLC grew its holdings by 294,430 shares, ending with 23,661,856 shares worth about $6,953,509,507 after a 1.3% increase. State Street Corporation grew its holdings by 290,606 shares, ending with 16,346,170 shares worth about $4,803,648,898 after a 1.8% increase. Morgan Stanley grew its holdings by 321,702 shares, ending with 9,728,195 shares worth about $2,858,824,617 after a 3.4% increase. Geode Capital Management, LLC grew its holdings by 124,398 shares, ending with 9,271,309 shares worth about $2,724,559,530 after a 1.4% increase.

CME Group Inc. Stock Up 0.3%

CME shares recently traded around $290.33 as of October 16, 2026. The stock sits about 6.3% above its 50-day moving average and roughly 4.2% above its 200-day moving average. It trades about 11.8% below its 52-week high of $329.16 and roughly 33.0% above its 52-week low of $218.31.

Recent Earnings

The company generated $6.76 billion in trailing twelve month revenue and reported earnings of $11.79 per share. Its net profit margin stood at 63.4%, and return on equity reached 15.8%. The next earnings release is scheduled for October 21, 2026.

Earnings drift grade

Outlook vs expectations on the last report — not price action.

F 28/100

Reported Apr 22, 2026

  1. Forward outlook

    2 target cuts vs 0 raises.

  2. EPS & revenue

    EPS missed estimates by 1.2%. Revenue missed estimates by 1.6%.

  3. Profit surprise

    EBITDA missed by 6 percent. Operating income missed by 5 percent.

  4. Pre-earnings setup

    Expectations were about average.

  5. Analyst signal

    2 target cuts.

  6. Earnings quality

    Gross margin up 0.7 points. Operating margin up 2.2 points. Positive free cash flow.

Earnings Call Summary

CME delivered a record first quarter with average daily volume of 36.2 million contracts, up 22 percent year-over-year, marking the highest in company history. Revenue reached $1.88 billion, up 14 percent, with record performance across all six asset classes and international markets. The company achieved record adjusted operating margins of 72.8 percent and adjusted earnings per share of $3.36, returning $3.2 billion to shareholders through dividends and buybacks.

Guidance CME reaffirmed its full-year adjusted expense guidance of about $1.695 billion. The company expects to continue investing in technology and cloud migration while maintaining capital returns through dividends and share buybacks.

Severe negative reset. The report materially damaged the forward outlook and likely forces major downward revisions.

Dividend

CME pays an annual dividend rate of $5.20 per share, giving it a dividend yield of 1.8% based on recent trading levels. The payout ratio sits at 95.4%.

Insider Buying and Selling at CME Group Inc.

Company insiders were active in the stock over recent months. Director William R Shepard bought 339 shares on June 25, 2026, at an average price of $230.57 for a total of $78,186. Chief Executive Officer Terrence A Duffy sold 15,000 shares on September 10, 2026, valued at $4,116,539. Director Elizabeth A Cook sold 500 shares on September 14, 2026, at an average price of $280.11 for a total of $140,055. Director William R Shepard bought another 292 shares on September 25, 2026, at $268.76 per share for a total of $78,626.

Analysts Set New Price Targets

Wall Street firms updated their outlooks on the stock through October 2026. On October 5, 2026, UBS maintained its Neutral rating and raised its price target to $270.00 from $260.00. On the same day, TD Cowen maintained a Buy rating and lifted its target to $300.00 from $292.00. Barclays maintained an Equal-Weight rating on October 7, 2026, and pushed its target up to $281.00 from $270.00. Morgan Stanley maintained an Overweight rating on October 9, 2026, moving its target to $337.00 from $330.00. Wells Fargo maintained an Overweight rating on October 14, 2026, and raised its target to $315.00 from $301.00. Across the street, the stock holds a consensus hold rating with a mean price target of $292.94 based on 16 analyst opinions.

About CME Group Inc.

CME Group operates global markets for trading futures and options contracts. It handles financial products tied to interest rates, foreign exchange, equity indexes, and commodities like energy, agriculture, and metals. Institutional investors rely on its clearing and exchange infrastructure to manage risk across global financial markets.

Bottom Line

Investors will look closely at the upcoming earnings report on October 21, 2026, to gauge ongoing revenue trends and volume growth. Future SEC filings will show whether TCV Trust & Wealth Management builds further on this initial stake. Keep in mind that 13F filings are backward-looking: they show holdings as of the end of the reporting quarter and may not represent the fund's current position.

Source: TCV Trust & Wealth Management's 13F filing on $CME (Oct 16, 2026). 13F filings show holdings as of the end of the reporting quarter and may not reflect the fund's current position. Read the original filing: 13F-HR filing on SEC EDGAR. Written by software, not financial advice. How we make alerts

Get $CME trade alerts by text